NCT06440304 - Therapeutic Options for CRAB | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions

Infections, BacterialSepsis Bacterial

Interventions

DRUG

Fosfomycin

Patients will be randomly divided according to a predetermined randomization table Upon arrival of a positive microbiological finding on A. baumannii, patient will be randomised to one of groups (Colistin with Unasyn OR Colistin with Xerava OR Colistin with Fosfomycin

DRUG

Eravacycline

Patients will be randomly divided according to a predetermined randomization table Upon arrival of a positive microbiological finding on A. baumannii, patient will be randomised to one of groups (Colistin with Unasyn OR Colistin with Xerava OR Colistin with Fosfomycin

DRUG

ampicillin/sulbactam

Patients will be randomly divided according to a predetermined randomization table Upon arrival of a positive microbiological finding on A. baumannii, patient will be randomised to one of groups (Colistin with Unasyn OR Colistin with Xerava OR Colistin with Fosfomycin

Trial Locations (1)

10000

RECRUITING

University Hospital Centre Zagreb, Zagreb